10:14 AM EST - Emerald Health Therapeutics Inc. : Has signed a definitive agreement with Northern Vine Canada Inc. and Abattis Bioceuticals Corp. to invest $2.5 million into Northern Vine to acquire a 53% stake in the company. Under the agreement Emerald Health can appoint three of the company’s four directors. Abattis will continue to hold the remaining 47% interest in Northern Vine. Emerald Health Therapeutics Inc.
shares V.EMH are trading up $0.05 at $1.51.
